http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/

BioTech Medics 1st Year Anniversary Report


DALLAS, Dec. 9 -- Keith Houser, CEO of BioTech
Medics, Inc., (OTC Pink Sheets: BTMD) issued a statement chronicling
the accomplishments during the first year anniversary of the
reverse/merger between Corbel Holdings, Inc., and HaloLaser
BioTherapy, LLC.

"During the past year BTMD has accomplished much," said Mr.
Houser. "We closed on the reverse/merger on time. The previous
directors and officers were replaced immediately. Under new
management and a new board of directors we hired a CPA firm to start
an audit of the merged companies. The auditors have completed IRS
filings through 2004, but not completed the audit. We pledged 'no
reverse stock split' and we have kept our word.

"BioTech Medics has acquired over $2.5 million in assets this
year (with cash and treasury stock) and has a steady revenue income
in the management agreement with Charles R. Crane MD & Associates in
forming our first Pain Management & Wellness Center in Dallas,
Texas. Additionally BTMD acquired 5 US Letters of Patent from FHJ
and have started marketing the proprietary SHBAN Cleaning &
Disinfecting Solution. BTMD entered into a distributorship
agreement with Laser Neurotherapy Development Labs and have sold the
NeuroLase Medical Laser device to clinics in the USA. We negotiated
turnkey financing for the laser acquisitions through First Financial
Leasing & Financing.

Mr. Houser stated: "In 2004 Corbel had under $500,000 in Real
Estate
Assets. Since the reverse/merger BTMD has had a 400% increase in non-
real
estate Assets. BTMD estimates to close 2005 with combined Gross
Revenues
around $ 1 million. The 2005 BTMD revenues are projected to be
nearly 20 times
higher than 2004.
"BTMD plans on closing on more new Pain Management & Wellness
Centers in
2006, as well as acquiring a permanent office building in Dallas,
Texas. We
pledge to strive to add more assets and increased revenue for the
company to
bring more value to the stock and its more than 5,800 shareholders
in 22
countries. This in turn should provide BTMD the opportunity to
become a
reporting company and the possibility to move up to a major
exchange."

For More Information Contact BioTech Medics at 972-274-5533 or
on the
Internet at: www.biotechmedics.com

Safe Harbor for Forward-Looking Statements
This press contains forward-looking statements within the
meaning of The
Private Securities Litigation Reform Act of 1995 (the "Act"). In
Particular,
when used in the preceding discussion, the words "plan," "expect,"
or "intend
to," and similar conditional expressions are intended to identify
forward-
looking statements within the meaning of the Act. Such statements
are subject
to certain risks and uncertainties and actual results could differ
materially
from those expressed. Such risks and uncertainties include, but are
not
limited to, the ability of the company to have adequate financing,
market
conditions, the general acceptance of the Company's products and
technologies,
competitive factors, timing, and other risks.

CONTACT: BioTech Medics, Inc., +1-972-274-5533

SOURCE BioTech Medics, Inc.
Web Site: www.biotechmedics.com

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech